Additionally, the levels of CD3, CD8 T cells, and CD20 B cells were lower in ALK+ NSCLC compared to KRAS+ NSCLC, while CD4 helper T cell levels were higher in ALK+ NSCLC than in EGFR/KRAS+ NSCLC. This evidence concerns the gene CD8A and non-small cell lung carcinoma.